Common Artificial Sweetener May Reduce Cancer Treatment Effectiveness

Sucralose may interfere with immunotherapy success, according to new research. 
Common Artificial Sweetener May Reduce Cancer Treatment Effectiveness
AS photo family/Shutterstock
|Updated:
0:00

A popular sugar substitute relied on by health-conscious consumers may interfere with life-saving cancer treatment, according to new research.

The study found that cancer patients who included high levels of the artificial sweetener sucralose in their diet had a poorer response to certain cancer-fighting drugs when compared to those who consumed less of the artificial sweetener.

How Sucralose Disrupts Cancer Treatment

The research, recently published in Cancer Discovery, examined 132 patients with advanced melanoma and non-small cell lung cancer, as well as animal studies that revealed the biological mechanism behind the connection.
George Citroner
George Citroner
Author
George Citroner reports on health and medicine, covering topics that include cancer, infectious diseases, and neurodegenerative conditions. He was awarded the Media Orthopaedic Reporting Excellence (MORE) award in 2020 for a story on osteoporosis risk in men.